Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications
Human Ig Kappa Light Chain Antibody MAB10050-100: R&D Systems
Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry | Journal of Translational Medicine | Full Text
Page 1 of 9 Title: Flow Cytometric Testing for Kappa and Lambda light chains Sponsored and reviewed by ICCS Quality and Standar
Development of a novel affinity chromatography resin for platform purification of lambda fabs - Eifler - 2014 - Biotechnology Progress - Wiley Online Library
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
A generic cell surface ligand system for studying cell–cell recognition | PLOS Biology
Introduction to Flow Cytometric Analysis | Flow Cytometry
Frontiers | The Role of the Pre-B Cell Receptor in B Cell Development, Repertoire Selection, and Tolerance
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Lambda-Carrageenan - an overview | ScienceDirect Topics
Case 966-- Clinical Chemistry Case
Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants | Journal of the American Chemical Society
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Regulation of protein secretion through chemical regulation of endoplasmic reticulum retention signal cleavage | Nature Communications
Evolution of the variant surface glycoprotein family in African trypanosomes: Trends in Parasitology
Protein L - Wikipedia
Frontiers | Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
Cells | Free Full-Text | The Role of Protein Disorder in Nuclear Transport and in Its Subversion by Viruses
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS